Form 4: Alice N. Schwartz, Director Emeritus at Bio-Rad Laboratories, Reports Changes in Beneficial Ownership

Alice N. Schwartz, a Director Emeritus at Bio-Rad Laboratories, filed a Form 4 detailing changes in her beneficial ownership of the company's stock due to a gift.

Summary

• On August 26, 2024, Alice N. Schwartz, a Director Emeritus of Bio-Rad Laboratories, reported changes in her beneficial ownership of Bio-Rad stock.
• The changes involve a gift of 3,190 shares of Bio-Rad A Common Stock and 342 shares of Bio-Rad B Common Stock.
• Following the transaction, Ms. Schwartz indirectly owns 1,781,356 shares of Bio-Rad A Common Stock through various trusts, including the Alice N. Schwartz Revocable Trust, David Schwartz Exemption Trust, David Schwartz Exempt Martial Trust, David Schwartz Non-Exempt Martial Trust, and a Charitable Remainder Unitrust.
• She also indirectly owns 437,510 shares of Bio-Rad B Common Stock through the Alice N. Schwartz Revocable Trust and the David Schwartz Non-Exempt Martial Trust.
• Additionally, she indirectly owns 4,060,054 shares of Bio-Rad B Common Stock through Blue Raven Partners, L.P., where she is a limited and general partner.

Sentiment

Score: 5

Explanation: This is a neutral regulatory filing, so the sentiment is neither positive nor negative.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions.

Key Dates